“…However, two doses of nanovaccine (12.5 and 50 µg antigen in CS NPs) inoculation only increased different TLRs mRNA expression and specific splenocytes proliferation, but did not induce high levels of antigen specific antibody response (Han et al, 2020c). Likewise, the oral administration of killed S. Enteritidis whole protein antigen encapsulated in CS NPs also failed to induce an adaptive immune response (Han et al, 2020c). Whereas, lower dose (10 µg antigen), vaccination at young age (3rd day), and two or three doses of nanovaccine administration heightened the systemic and mucosal antibody, cell mediated immune response, TLRs gene expression, resulting in reduced S. Enteritidis load in the cecum (Han et al, 2020a).…”